β-amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease

被引：67

作者：

Andreasen, N ^{[1
]}

Blennow, K

机构：

[1] Huddinge Univ Hosp, Karolinska Inst, Neurotec, Dept Geriatr Med, SE-14186 Stockholm, Sweden

[2] Univ Gothenburg, Dept Clin Neurosci, Unit Neurochem, Gothenburg, Sweden

[3] MRC, Stockholm, Sweden

来源：

PEPTIDES | 2002年 / 23卷 / 07期

关键词：

Alzheimer's disease (AD); beta-amyloid (A beta); biochemical markers; cerebrospinal fluid (CSF); plasma; diagnosis;

D O I：

10.1016/S0196-9781(02)00056-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

With the arrival of symptomatic treatment (acetylcholine esterase inhibitors) and the promise of drugs that may delay disease progression, development of diagnostic biomarkers for Alzheimer's disease (AD) are important. beta-Amyloid (Abeta) protein is the main component of senile plaques. A marked reduction in cerebrospinal nuid (CSF)-Abeta42 in AD has been found in numerous studies. Importantly, reduced CSF-Abeta42 is also found very early in the disease process, before the onset of clinical symptoms. Recent studies suggest that CSF-Abeta42 have a satisfactory performance when used as a diagnostic marker for AD in clinical routine. This paper reviews CSF-Abeta42 as a biomarker for AD. (C) 2002 Elsevier Science Inc. All rights reserved.

引用

页码：1205 / 1214

页数：10

共 100 条

[21] AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM
HAASS, C
SCHLOSSMACHER, MG
HUNG, AY
VIGOPELFREY, C
MELLON, A
OSTASZEWSKI, BL
LIEBERBURG, I
KOO, EH
SCHENK, D
TEPLOW, DB
SELKOE, DJ
[J]. NATURE, 1992, 359 (6393) : 322 - 325
[22] AMYLOID DEPOSITION AS THE CENTRAL EVENT IN THE ETIOLOGY OF ALZHEIMERS-DISEASE
HARDY, J
ALLSOP, D
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (10) : 383 - 388
[23] PRESENILE-DEMENTIA AND CEREBRAL-HEMORRHAGE LINKED TO A MUTATION AT CODON-692 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE
HENDRIKS, L
VANDUIJN, CM
CRAS, P
CRUTS, M
VANHUL, W
VANHARSKAMP, F
WARREN, A
MCINNIS, MG
ANTONARAKIS, SE
MARTIN, JJ
HOFMAN, A
VAN BROECKHOVEN, C
[J]. NATURE GENETICS, 1992, 1 (03) : 218 - 221
[24] Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199
[25] AGGREGATION AND SECONDARY STRUCTURE OF SYNTHETIC AMYLOID BETA-A4 PEPTIDES OF ALZHEIMERS-DISEASE
HILBICH, C
KISTERSWOIKE, B
REED, J
MASTERS, CL
BEYREUTHER, K
[J]. JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (01) : 149 - 163
[26] Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF
Hulstaert, F
Blennow, K
Ivanoiu, A
Schoonderwaldt, HC
Riemenschneider, M
De Deyn, PP
Bancher, C
Cras, P
Wiltfang, J
Mehta, PD
Iqbal, K
Pottel, H
Vanmechelen, E
Vanderstichele, H
[J]. NEUROLOGY, 1999, 52 (08) : 1555 - 1562
[27] Analysis of heterogeneous beta A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay
Ida, N
Hartmann, T
Pantel, J
Schroder, J
Zerfass, R
Forstl, H
Sandbrink, R
Masters, CL
Beyreuther, K
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) : 22908 - 22914
[28] VISUALIZATION OF A-BETA-42(43) AND A-BETA-40 IN SENILE PLAQUES WITH END-SPECIFIC A-BETA MONOCLONALS - EVIDENCE THAT AN INITIALLY DEPOSITED SPECIES IS A-BETA-42(43)
IWATSUBO, T
ODAKA, A
SUZUKI, N
MIZUSAWA, H
NUKINA, N
IHARA, Y
[J]. NEURON, 1994, 13 (01) : 45 - 53
[29] THE CARBOXY TERMINUS OF THE BETA-AMYLOID PROTEIN IS CRITICAL FOR THE SEEDING OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE
JARRETT, JT
BERGER, EP
LANSBURY, PT
[J]. BIOCHEMISTRY, 1993, 32 (18) : 4693 - 4697
[30] Diagnostic accuracy of Alzheimer's disease: A clinicopathological study
Jellinger, KA
[J]. ACTA NEUROPATHOLOGICA, 1996, 91 (02) : 219 - 220

← 1 2 3 4 5 6 7 8 9 10 →